USPH

USPH

USD

U.S. Physical Therapy Inc. Common Stock

$70.530+1.050 (1.511%)

Prix en Temps Réel

Healthcare
Medical Care Facilities
États-Unis

Graphique des Prix

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$69.480

Haut

$73.680

Bas

$69.040

Volume

0.01M

Fondamentaux de l'Entreprise

Capitalisation Boursière

1.1B

Industrie

Medical Care Facilities

Pays

United States

Statistiques de Trading

Volume Moyen

0.12M

Bourse

NYQ

Devise

USD

Intervalle sur 52 Semaines

Bas $62.77Actuel $70.530Haut $108.14

Rapport d'Analyse IA

Dernière mise à jour: 26 avr. 2025
Généré par l'IASource des Données: Yahoo Finance, Bloomberg, SEC

USPH (U.S. Physical Therapy Inc. Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: USPH Generate Date: 2025-04-26 22:52:53

Let's break down what's been happening with U.S. Physical Therapy stock lately, looking at the news, how the price has moved, and what some predictions are saying.

Recent News Buzz

What's the latest chatter around USPH? Well, there are a couple of recent announcements.

First off, the company just set the date for its first-quarter 2025 earnings report and conference call. This is pretty standard stuff – companies have to tell everyone how they did financially. It's not good or bad news on its own, but it means we'll get a clearer picture of the company's health soon, which could definitely move the stock.

More interestingly, an analyst over at JMP Securities recently reiterated their "Market Outperform" rating on USPH. Think of this as an analyst saying, "Hey, I think this stock is going to do better than the overall market." Not only that, they stuck with a price target of $113. That's a pretty strong vote of confidence from a professional observer, especially when you look at where the stock price is right now.

So, the news vibe is a bit mixed – one routine announcement, but one clear positive signal from an analyst who thinks the stock has significant room to grow.

Price Check: What's the Stock Been Doing?

Now, let's look at the stock's actual performance over the past few months. It's been a bit of a rough ride. Back in late January, the stock was trading up around $89 to $91. From there, it generally trended downwards, sometimes quite sharply. It hit its 52-week low of $62.77 just recently, in early April.

Since hitting that low, the price has bounced back a bit. The last recorded price was $70.53. So, while it's still way down from where it was earlier in the year and far below that $113 analyst target, it has shown some signs of stabilizing and recovering slightly from its lowest point. The trading volume has been a bit up and down, sometimes seeing spikes on big price moves.

What about the super short-term? An AI prediction model suggests the price might stay pretty flat or tick up just slightly over the next couple of days (predictions of +0.0%, +0.13%, +0.11%). This doesn't point to any immediate big moves, just maybe a bit of gentle upward drift or sideways trading right now.

Putting It Together: Outlook & Ideas

Okay, let's connect the dots. You've got an analyst who's quite bullish, seeing the stock potentially going to $113, while the stock itself has been in a significant decline but recently found a floor around the low $60s and bounced into the low $70s. The AI sees minimal movement right now.

Based on this mix, the situation might lean towards a potential 'buy' or 'accumulate' window for investors who believe the analyst's long-term view is realistic. The stock is trading far below its previous highs and the analyst's target, and it's just bounced off its 52-week low.

If someone were considering getting involved, a potential entry area could be around the current price ($70.53) or perhaps waiting to see if it dips back slightly towards that recent low point in the mid-$60s. The idea here is potentially buying low relative to where the analyst thinks it's headed.

For managing risk, setting a stop-loss just below that recent 52-week low, maybe around $63.48 (as suggested by some data), could be a sensible move. This level is below where the stock recently bounced, so if it falls below that, it could signal the downtrend is resuming. On the flip side, if the stock starts climbing, a potential take-profit level for a shorter-term trade might be around $75.84, which is indicated as a potential target in some analysis.

Company Context

Just a quick reminder about the company itself: U.S. Physical Therapy runs physical therapy clinics and also provides injury prevention services to businesses. They're in the Healthcare sector, specifically Medical Care Facilities. Knowing this helps understand that things affecting healthcare demand or workplace safety trends could impact their business. The company has a market cap of around $1 billion and a P/E ratio around 24, which gives you a sense of its size and how expensive it is relative to its earnings. It's important to remember how much the stock has fallen from its 52-week high of $108.14 to the recent low of $62.77 – that's a big drop, highlighting the volatility and risk involved.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock investing involves risk, and you could lose money. Always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.

Actualités Connexes

BusinessWire

U.S. Physical Therapy, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call Dates

U.S. Physical Therapy, Inc. (NYSE:USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services, announced that it will report its financial results for the

Voir plus
U.S. Physical Therapy, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call Dates
Analyst Upgrades

JMP Securities Reiterates Market Outperform on US Physical Therapy, Maintains $113 Price Target

JMP Securities analyst Constantine Davides reiterates US Physical Therapy with a Market Outperform and maintains $113 price target.

Voir plus
JMP Securities Reiterates Market Outperform on US Physical Therapy, Maintains $113 Price Target

Prédiction IABeta

Recommandation IA

Haussier

Mis à jour le: 28 avr. 2025, 02:27

BaissierNeutreHaussier

65.4% Confiance

Risque et Trading

Niveau de Risque3/5
Risque Moyen
Adapté Pour
Modéré
Guide de Trading

Point d'Entrée

$70.02

Prise de Bénéfices

$75.85

Stop Loss

$63.48

Facteurs Clés

Le PDI 13.6 est au-dessus du MDI 10.6 avec un ADX de 8.2, suggérant une tendance haussière
Le cours actuel est extrêmement proche du niveau de support ($70.20), suggérant une forte opportunité d'achat
Le volume de transactions est 5.6x la moyenne (1,637), indiquant une pression d'achat extrêmement forte
Le MACD 0.1223 est au-dessus de la ligne de signal 0.0997, indiquant un croisement haussier

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.